Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 20:7:24.
doi: 10.1186/1748-717X-7-24.

Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

Markus K A Herrmann  1 , Tereza Kertesz, Tammo Gsänger, Eugen Bloch, Gerhard Pollul, Mohamed Bouabdallaoui, Arne Strauss, Mareike Herrmann, Hans Christiansen, Hendrik A Wolff, Clemens F Hess, Andrea Hille
Affiliations

Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

Markus K A Herrmann et al. Radiat Oncol. .

Abstract

Purpose: To evaluate gold marker displacement due to needle insertion during HDR-brachytherapy for therapy of prostate cancer.

Patients and methods: 18 patients entered into this prospective evaluation. Three gold markers were implanted into the prostate during the first HDR-brachytherapy procedure after the irradiation was administered. Three days after marker implantation all patients had a CT-scan for planning purpose of the percutaneous irradiation. Marker localization was defined on the digitally-reconstructed-radiographs (DRR) for daily (VMAT technique) or weekly (IMRT) set-up error correction. Percutaneous therapy started one week after first HDR-brachytherapy. After the second HDR-brachytherapy, two weeks after first HDR-brachtherapy, a cone-beam CT-scan was done to evaluate marker displacement due to needle insertion. In case of marker displacement, the actual positions of the gold markers were adjusted on the DRR.

Results: The value of the gold marker displacement due to the second HDR-brachytherapy was analyzed in all patients and for each gold marker by comparison of the marker positions in the prostate after soft tissue registration of the prostate of the CT-scans prior the first and second HDR-brachytherapy. The maximum deviation was 5 mm, 7 mm and 12 mm for the anterior-posterior, lateral and superior-inferior direction. At least one marker in each patient showed a significant displacement and therefore new marker positions were adjusted on the DRRs for the ongoing percutaneous therapy.

Conclusions: Needle insertion in the prostate due to HDR-brachytherapy can lead to gold marker displacements. Therefore, it is necessary to verify the actual position of markers after the second HDR-brachytherapy. In case of significant deviations, a new DRR with the adjusted marker positions should be generated for precise positioning during the ongoing percutaneous irradiation.

PubMed Disclaimer

References

    1. Harris EJ, McNair HA, Evans PM. Feasibility of fully automated detection of fiducial markers implanted into the prostate using electronic portal imaging: a comparison of methods. Int J Radiat Oncol Biol Phys. 2006;66:1263–1270. doi: 10.1016/j.ijrobp.2006.07.1363. - DOI - PubMed
    1. Osei EK, Jiang R, Barnett R, Fleming K, Panjwani D. Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate. Br J Radiol. 2009;82:49–61. doi: 10.1259/bjr/58088207. - DOI - PubMed
    1. Owen R, Kron T, Foroudi F, Cox J, Zhu L, Cramb J. et al.The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI) Med Dosim. 2008;33:226–233. doi: 10.1016/j.meddos.2007.12.002. - DOI - PubMed
    1. Schiffner DC, Gottschalk AR, Lometti M, Aubin M, Pouliot J, Speight J. et al.Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007;67:610–619. doi: 10.1016/j.ijrobp.2006.09.042. - DOI - PubMed
    1. Van den Heuvel F, Fugazzi J, Seppi E, Forman JD. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol. 2006;79:94–100. doi: 10.1016/j.radonc.2006.03.002. - DOI - PubMed

Substances